223797-21-5

Usage

Uses

Used in Medicinal Chemistry and Drug Development:
1-(6-Bromo-3-pyridyl)homopiperazine is utilized as a building block for the synthesis of potential pharmaceutical agents. Its unique structure allows for the creation of various compounds with possible therapeutic applications.
Used in the Pharmaceutical Industry:
In the pharmaceutical industry, 1-(6-Bromo-3-pyridyl)homopiperazine is used as a precursor for developing new drugs. Its potential biological activities, such as antipsychotic and anti-inflammatory properties, make it a promising candidate for further research and development.
Used in Research and Development:
1-(6-Bromo-3-pyridyl)homopiperazine is employed as a research compound to study its pharmacological properties and potential applications. Further research is necessary to fully understand its capabilities and how it can be effectively utilized in the development of new medications.

InChI:InChI=1/C10H14BrN3/c11-10-3-2-9(8-13-10)14-6-1-4-12-5-7-14/h2-3,8,12H,1,4-7H2

Upstream product

• 223797-58-8 t-butyl 4-(6-bromopyridin-3-yl)-1,4-diazepane-1-carboxylate 
• 112275-50-0 tert-butyl 1,4-diazepine-1-carboxylate 
• 223797-48-6 1-(pyridin-3-yl)-4-tert-butoxycarbonylhomopiperazine 
• 626-55-1 3-Bromopyridine 
• 223796-20-1 1-(pyridin-3-yl)-homopiperazine 

Relevant academic research and scientific papers

Exploration of the molecular architecture of the orthosteric binding site in the α4β2 nicotinic acetylcholine receptor with analogs of 3-(dimethylamino)butyl dimethylcarbamate (DMABC) and 1-(pyridin-3-yl)-1,4-diazepane

X-ray crystal structures of acetylcholine binding proteins (AChBPs) have revealed two different possible extensions to the classical ligand binding pocket known to accommodate various nicotinic agonists. One of the pockets is limited in size while the oth

Heteroaryl diazacycloalkanes, their preparation and use;

The present invention discloses compounds of the formula any of its enantiomers or any mixture thereof, isotopes thereof or a pharmaceutically acceptable salt thereof; wherein n is 1, 2 or 3; m is 0, 1 or 2; R represents hydrogen, alkyl, cycloalkyl, cyclo

Novel potent ligands for the central nicotinic acetylcholine receptor: Synthesis, receptor binding, and 3D-QSAR analysis

In the past few years the focus on central acetylcholine receptors has shifted from-compounds with affinity for muscarinic acetylcholine receptors (mAChR) to compounds with affinity for nicotinic acetylcholine receptors (nAChR). The therapeutic potential